Open AccessEndogenous DOPA inhibits melanoma through suppression of CHRM1 signaling
Author(s) -
Miriam Doepner,
Inyoung Lee,
Christopher A. Natale,
Roderick Brathwaite,
Swati Venkat,
Sung Hoon Kim,
Yiliang Wei,
Christopher R. Vakoc,
Brian C. Capell,
John A. Katzenellenbogen,
Benita S. Katzenellenbogen,
Michael E. Feigin,
Todd W. Ridky
Publication year - 2022
Publication title -
science advances
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.928
H-Index - 146
ISSN - 2375-2548
DOI - 10.1126/sciadv.abn4007
Subject(s) - melanoma , melanocyte , melanin , cancer research , human skin , dihydroxyphenylalanine , biology , cell growth , endogeny , in vivo , neuroscience , endocrinology , genetics , dopamine
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom